Solid Tumor Program
Our Pediatric Solid Tumor Program provides specialized evaluation, diagnosis and care for children, teens and young adults with solid tumors, including neuroblastoma, hepatoblastoma, bone and soft tissue sarcomas, Wilms' tumors and other cancers. We also care for patients whose cancers have relapsed. Our team is known globally for taking on rare and challenging cases.
At UCSF, we believe cancer therapy works best when it is tailored to each patient's disease. Every one of our patients is unique, and our program offers high-quality, targeted care that is precise, effective and compassionate. We evaluate patients using the most advanced diagnostic tools, including genetic tests developed here at UCSF and not offered at other hospitals. Our patients also have access to new treatments that aren't widely available or that are still being evaluated in clinical trials. We're the only hospital in Northern California that's a member of the Oncology Group Phase 1/Pilot Consortium, a small group of leading institutions tasked by the National Cancer Institute with developing new therapies for pediatric cancers.
Our team understands that cancer treatment is an intensely personal experience for each child and family. That's why we draw on the expertise of nurse practitioners, psychologists, social workers and child life specialists to ensure that you and your child receive the support you need. It's also why we strive to make as much of your child's care as possible happen close to home — through telehealth and collaboration with health care providers in your community.
To schedule an appointment with the Pediatric Solid Tumor Program, please call (415) 476-3831.
Please note that many insurance plans require a referral from your child's primary care doctor before you can schedule a visit at UCSF. We ask that you contact your insurance carrier to check whether you need this. If a referral is required, please ask your child's primary care provider to fax a referral form and any applicable medical records to the UCSF Pediatric Access Center at (415) 353-4485.
Our locations (1)
Robert E. Goldsby
W. Clay Gustafson
Katherine K. Matthay
Amit J. Sabnis
MD, MSPediatric hematologist-oncologist
PNP, MSNPediatric nurse practitioner
FNP, MSNFamily nurse practitioner
Awards & recognition
Best in Northern California for cancer care
Ranked among the nation's best in 10 specialties
patients treated with MIBG therapy, a leading-edge neuroblastoma treatment
Plan your visit
What to Bring
- Photo I.D.
- Health insurance card
- Insurance authorization, if required
- Doctor's referral, if required
- Recent test results related to your child's condition
- List of medications, including dosages, plus any your child is allergic to
- List of questions you may have
- Device or paper for taking notes
Related clinics (7)
Precision Cancer Medicine Program
Orthopedic Surgical Oncology Clinic
Blood & Marrow Transplant (BMT) Clinic
Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders W...
Will be determined by Response Evaluation Criteria in Solid Tumors. Response rates will be calculated as the percent of evaluable patients who are responders, and confidence intervals will be constructed using the Wilson score int...
Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With ...
A responder is defined as a patient who achieves a best response of partial response or complete response on the study. Response rates will be calculated as the percent of evaluable patients who are responders, and confidence inte...
Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Re...
Response rates will be calculated as the percent of evaluable patients who are responders, and confidence intervals will be constructed using the Wilson score interval method.
Our research initiatives
UCSF Children's Cancer Program Clinical Trials
Smell the roses